{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,18]],"date-time":"2026-11-18T13:54:58Z","timestamp":1795010098196,"version":"4.9.1"},"reference-count":76,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2021,1,4]],"date-time":"2021-01-04T00:00:00Z","timestamp":1609718400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2021,1,4]],"date-time":"2021-01-04T00:00:00Z","timestamp":1609718400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Biomed Eng"],"DOI":"10.1038\/s41551-020-00656-y","type":"journal-article","created":{"date-parts":[[2021,1,4]],"date-time":"2021-01-04T12:07:03Z","timestamp":1609762023000},"page":"144-156","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":178,"title":["Lentiviral delivery of co-packaged Cas9 mRNA and a Vegfa-targeting guide RNA prevents wet age-related macular degeneration in mice"],"prefix":"10.1038","volume":"5","author":[{"given":"Sikai","family":"Ling","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shiqi","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xinde","family":"Hu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Di","family":"Yin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yao","family":"Dai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoqing","family":"Qian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1556-1594","authenticated-orcid":false,"given":"Dawei","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoyong","family":"Pan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiaxu","family":"Hong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaodong","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3590-722X","authenticated-orcid":false,"given":"Hui","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9180-4060","authenticated-orcid":false,"given":"Soren Riis","family":"Paludan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2955-7289","authenticated-orcid":false,"given":"Yujia","family":"Cai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,1,4]]},"reference":[{"key":"656_CR1","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1038\/nature20134","volume":"539","author":"DP Dever","year":"2016","unstructured":"Dever, D. P. et al. CRISPR\/Cas9 \u03b2-globin gene targeting in human haematopoietic stem cells. Nature 539, 384\u2013389 (2016).","journal-title":"Nature"},{"key":"656_CR2","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1101\/gr.219089.116","volume":"27","author":"K Kim","year":"2017","unstructured":"Kim, K. et al. Genome surgery using Cas9 ribonucleoproteins for the treatment of age-related macular degeneration. Genome Res. 27, 419\u2013426 (2017).","journal-title":"Genome Res."},{"key":"656_CR3","doi-asserted-by":"crossref","first-page":"e1005701","DOI":"10.1371\/journal.ppat.1005701","volume":"12","author":"FR van Diemen","year":"2016","unstructured":"van Diemen, F. R. et al. CRISPR\/Cas9-mediated genome editing of herpesviruses limits productive and latent infections. PLoS Pathog. 12, e1005701 (2016).","journal-title":"PLoS Pathog."},{"key":"656_CR4","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1038\/s41591-018-0327-9","volume":"25","author":"ML Maeder","year":"2019","unstructured":"Maeder, M. L. et al. Development of a gene-editing approach to restore vision loss in Leber congenital amaurosis type 10. Nat. Med. 25, 229\u2013233 (2019).","journal-title":"Nat. Med."},{"key":"656_CR5","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1038\/s41591-019-0343-4","volume":"25","author":"E Beyret","year":"2019","unstructured":"Beyret, E. et al. Single-dose CRISPR-Cas9 therapy extends lifespan of mice with Hutchinson\u2013Gilford progeria syndrome. Nat. Med. 25, 419\u2013422 (2019).","journal-title":"Nat. Med."},{"key":"656_CR6","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1038\/s41591-018-0338-6","volume":"25","author":"O Santiago-Fernandez","year":"2019","unstructured":"Santiago-Fernandez, O. et al. Development of a CRISPR\/Cas9-based therapy for Hutchinson\u2013Gilford progeria syndrome. Nat. Med. 25, 423\u2013426 (2019).","journal-title":"Nat. Med."},{"key":"656_CR7","volume":"8","author":"E Kim","year":"2017","unstructured":"Kim, E. et al. In vivo genome editing with a small Cas9 orthologue derived from Campylobacter jejuni. Nat. Commun. 8, 14500 (2017).","journal-title":"Nat. Commun."},{"key":"656_CR8","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/j.omtm.2018.11.009","volume":"12","author":"A Li","year":"2019","unstructured":"Li, A. et al. A self-deleting AAV-CRISPR system for in vivo genome editing. Mol. Ther. Methods Clin. Dev. 12, 111\u2013122 (2019).","journal-title":"Mol. Ther. Methods Clin. Dev."},{"key":"656_CR9","doi-asserted-by":"crossref","first-page":"868","DOI":"10.1038\/nmeth.3993","volume":"13","author":"WL Chew","year":"2016","unstructured":"Chew, W. L. et al. A multifunctional AAV-CRISPR-Cas9 and its host response. Nat. Methods 13, 868\u2013874 (2016).","journal-title":"Nat. Methods"},{"key":"656_CR10","doi-asserted-by":"crossref","first-page":"194ra192","DOI":"10.1126\/scitranslmed.3005795","volume":"5","author":"F Mingozzi","year":"2013","unstructured":"Mingozzi, F. et al. Overcoming preexisting humoral immunity to AAV using capsid decoys. Sci. Transl. Med. 5, 194ra192 (2013).","journal-title":"Sci. Transl. Med."},{"key":"656_CR11","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1038\/s41591-019-0344-3","volume":"25","author":"CE Nelson","year":"2019","unstructured":"Nelson, C. E. et al. Long-term evaluation of AAV-CRISPR genome editing for Duchenne muscular dystrophy. Nat. Med. 25, 427\u2013432 (2019).","journal-title":"Nat. Med."},{"key":"656_CR12","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1038\/s41591-018-0204-6","volume":"25","author":"DL Wagner","year":"2019","unstructured":"Wagner, D. L. et al. High prevalence of Streptococcus pyogenes Cas9-reactive T cells within the adult human population. Nat. Med. 25, 242\u2013248 (2019).","journal-title":"Nat. Med."},{"key":"656_CR13","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1007\/s40472-019-00237-2","volume":"6","author":"T Wignakumar","year":"2019","unstructured":"Wignakumar, T. & Fairchild, P. J. Evasion of pre-existing immunity to Cas9: a prerequisite for successful genome editing in vivo? Curr. Transplant. Rep. 6, 127\u2013133 (2019).","journal-title":"Curr. Transplant. Rep."},{"key":"656_CR14","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1038\/nature25164","volume":"553","author":"X Gao","year":"2018","unstructured":"Gao, X. et al. Treatment of autosomal dominant hearing loss by in vivo delivery of genome editing agents. Nature 553, 217\u2013221 (2018).","journal-title":"Nature"},{"key":"656_CR15","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1016\/j.omtn.2018.05.010","volume":"12","author":"C Montagna","year":"2018","unstructured":"Montagna, C. et al. VSV-G-enveloped vesicles for traceless delivery of CRISPR-Cas9. Mol. Ther. Nucleic Acids 12, 453\u2013462 (2018).","journal-title":"Mol. Ther. Nucleic Acids"},{"key":"656_CR16","doi-asserted-by":"crossref","first-page":"889","DOI":"10.1038\/s41551-017-0137-2","volume":"1","author":"K Lee","year":"2017","unstructured":"Lee, K. et al. Nanoparticle delivery of Cas9 ribonucleoprotein and donor DNA in vivo induces homology-directed DNA repair. Nat. Biomed. Eng. 1, 889\u2013901 (2017).","journal-title":"Nat. Biomed. Eng."},{"key":"656_CR17","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1038\/s41551-018-0252-8","volume":"2","author":"B Lee","year":"2018","unstructured":"Lee, B. et al. Nanoparticle delivery of CRISPR into the brain rescues a mouse model of fragile X syndrome from exaggerated repetitive behaviours. Nat. Biomed. Eng. 2, 497\u2013507 (2018).","journal-title":"Nat. Biomed. Eng."},{"key":"656_CR18","doi-asserted-by":"crossref","first-page":"1124","DOI":"10.1038\/s41563-019-0385-5","volume":"18","author":"R Shahbazi","year":"2019","unstructured":"Shahbazi, R. et al. Targeted homology-directed repair in blood stem and progenitor cells with CRISPR nanoformulations. Nat. Mater. 18, 1124\u20131132 (2019).","journal-title":"Nat. Mater."},{"key":"656_CR19","doi-asserted-by":"crossref","first-page":"2313","DOI":"10.1007\/s11051-010-9911-8","volume":"12","author":"AM Alkilany","year":"2010","unstructured":"Alkilany, A. M. & Murphy, C. J. Toxicity and cellular uptake of gold nanoparticles: what we have learned so far? J. Nanopart. Res. 12, 2313\u20132333 (2010).","journal-title":"J. Nanopart. Res."},{"key":"656_CR20","doi-asserted-by":"crossref","first-page":"e02904","DOI":"10.7554\/eLife.02904","volume":"3","author":"NVS Perry B Hackett","year":"2014","unstructured":"Perry B Hackett, N. V. S. Gene therapy: delivering the second revolution in site-specific nucleases. eLife 3, e02904 (2014).","journal-title":"eLife"},{"key":"656_CR21","doi-asserted-by":"crossref","first-page":"194","DOI":"10.2174\/1566523216666160527143702","volume":"16","author":"Y Cai","year":"2016","unstructured":"Cai, Y. & Mikkelsen, J. G. Lentiviral delivery of proteins for genome engineering. Curr. Gene Ther. 16, 194\u2013206 (2016).","journal-title":"Curr. Gene Ther."},{"key":"656_CR22","doi-asserted-by":"crossref","first-page":"1101","DOI":"10.1126\/science.aah6192","volume":"353","author":"L Naldini","year":"2016","unstructured":"Naldini, L., Trono, D. & Verma, I. M. Lentiviral vectors, two decades later. Science 353, 1101\u20131102 (2016).","journal-title":"Science"},{"key":"656_CR23","doi-asserted-by":"crossref","first-page":"e01911","DOI":"10.7554\/eLife.01911","volume":"3","author":"Y Cai","year":"2014","unstructured":"Cai, Y., Bak, R. O. & Mikkelsen, J. G. Targeted genome editing by lentiviral protein transduction of zinc-finger and TAL-effector nucleases. eLife 3, e01911 (2014).","journal-title":"eLife"},{"key":"656_CR24","doi-asserted-by":"crossref","first-page":"e28","DOI":"10.1093\/nar\/gkt1163","volume":"42","author":"Y Cai","year":"2014","unstructured":"Cai, Y. et al. DNA transposition by protein transduction of the PiggyBac transposase from lentiviral Gag precursors. Nucleic Acids Res. 42, e28 (2014).","journal-title":"Nucleic Acids Res."},{"key":"656_CR25","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1038\/gt.2016.27","volume":"23","author":"JG Choi","year":"2016","unstructured":"Choi, J. G. et al. Lentivirus pre-packed with Cas9 protein for safer gene editing. Gene Ther. 23, 627\u2013633 (2016).","journal-title":"Gene Ther."},{"key":"656_CR26","doi-asserted-by":"crossref","first-page":"e44","DOI":"10.1093\/nar\/gkz093","volume":"47","author":"B Lu","year":"2019","unstructured":"Lu, B. et al. Delivering SaCas9 mRNA by lentivirus-like bionanoparticles for transient expression and efficient genome editing. Nucleic Acids Res. 47, e44 (2019).","journal-title":"Nucleic Acids Res."},{"key":"656_CR27","doi-asserted-by":"crossref","first-page":"e99","DOI":"10.1093\/nar\/gkz605","volume":"47","author":"P Lyu","year":"2019","unstructured":"Lyu, P., Javidi-Parsijani, P., Atala, A. & Lu, B. Delivering Cas9\/sgRNA ribonucleoprotein (RNP) by lentiviral capsid-based bionanoparticles for efficient \u2018hit-and-run\u2019 genome editing. Nucleic Acids Res. 47, e99 (2019).","journal-title":"Nucleic Acids Res."},{"key":"656_CR28","doi-asserted-by":"crossref","first-page":"7805","DOI":"10.1073\/pnas.0914517107","volume":"107","author":"C Voelkel","year":"2010","unstructured":"Voelkel, C. et al. Protein transduction from retroviral Gag precursors. Proc. Natl Acad. Sci. USA 107, 7805\u20137810 (2010).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"656_CR29","doi-asserted-by":"crossref","first-page":"15039","DOI":"10.1038\/mtm.2015.39","volume":"2","author":"A Prel","year":"2015","unstructured":"Prel, A. et al. Highly efficient in vitro and in vivo delivery of functional RNAs using new versatile MS2-chimeric retrovirus-like particles. Mol. Ther. Methods Clin. Dev. 2, 15039 (2015).","journal-title":"Mol. Ther. Methods Clin. Dev."},{"key":"656_CR30","doi-asserted-by":"crossref","DOI":"10.1038\/s41467-018-07845-z","volume":"10","author":"PE Mangeot","year":"2019","unstructured":"Mangeot, P. E. et al. Genome editing in primary cells and in vivo using viral-derived nanoblades loaded with Cas9-sgRNA ribonucleoproteins. Nat. Commun. 10, 45 (2019).","journal-title":"Nat. Commun."},{"key":"656_CR31","doi-asserted-by":"crossref","first-page":"1728","DOI":"10.1016\/S0140-6736(12)60282-7","volume":"379","author":"LS Lim","year":"2012","unstructured":"Lim, L. S., Mitchell, P., Seddon, J. M., Holz, F. G. & Wong, T. Y. Age-related macular degeneration. Lancet 379, 1728\u20131738 (2012).","journal-title":"Lancet"},{"key":"656_CR32","doi-asserted-by":"crossref","first-page":"502","DOI":"10.1097\/ICU.0b013e3282f0ca54","volume":"18","author":"CM Andreoli","year":"2007","unstructured":"Andreoli, C. M. & Miller, J. W. Anti-vascular endothelial growth factor therapy for ocular neovascular disease. Curr. Opin. Ophthalmol. 18, 502\u2013508 (2007).","journal-title":"Curr. Opin. Ophthalmol."},{"key":"656_CR33","doi-asserted-by":"crossref","first-page":"3032","DOI":"10.1172\/JCI129862","volume":"129","author":"A Usui-Ouchi","year":"2019","unstructured":"Usui-Ouchi, A. & Friedlander, M. Anti-VEGF therapy: higher potency and long-lasting antagonism are not necessarily better. J. Clin. Invest. 129, 3032\u20133034 (2019).","journal-title":"J. Clin. Invest."},{"key":"656_CR34","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1089\/hum.2016.117","volume":"28","author":"PA Campochiaro","year":"2017","unstructured":"Campochiaro, P. A. et al. Lentiviral vector gene transfer of endostatin\/angiostatin for macular degeneration (GEM) study. Hum. Gene Ther. 28, 99\u2013111 (2017).","journal-title":"Hum. Gene Ther."},{"key":"656_CR35","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1016\/j.omtm.2018.11.005","volume":"13","author":"CP Hughes","year":"2019","unstructured":"Hughes, C. P. et al. AAV2\/8 anti-angiogenic gene therapy using single-chain antibodies inhibits murine choroidal neovascularization. Mol. Ther. Methods Clin. Dev. 13, 86\u201398 (2019).","journal-title":"Mol. Ther. Methods Clin. Dev."},{"key":"656_CR36","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1089\/hum.2009.102","volume":"21","author":"Y Murakami","year":"2009","unstructured":"Murakami, Y. et al. Inhibition of choroidal neovascularization via brief subretinal exposure to a newly developed lentiviral vector pseudotyped with sendai viral envelope proteins. Hum. Gene Ther. 21, 199\u2013209 (2009).","journal-title":"Hum. Gene Ther."},{"key":"656_CR37","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/j.omtm.2017.04.002","volume":"5","author":"PI Ortinski","year":"2017","unstructured":"Ortinski, P. I., O\u2019Donovan, B., Dong, X. & Kantor, B. Integrase-deficient lentiviral vector as an all-in-one platform for highly efficient CRISPR\/Cas9-mediated gene editing. Mol. Ther. Methods Clin. Dev. 5, 153\u2013164 (2017).","journal-title":"Mol. Ther. Methods Clin. Dev."},{"key":"656_CR38","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.omtn.2017.11.001","volume":"10","author":"D S\u00fcr\u00fcn","year":"2018","unstructured":"S\u00fcr\u00fcn, D. et al. High efficiency gene correction in hematopoietic cells by donor-template-free CRISPR\/Cas9 genome editing. Mol. Ther. Nucleic Acids 10, 1\u20138 (2018).","journal-title":"Mol. Ther. Nucleic Acids"},{"key":"656_CR39","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/j.omtn.2017.08.016","volume":"9","author":"A Holmgaard","year":"2017","unstructured":"Holmgaard, A. et al. In vivo knockout of the Vegfa gene by lentiviral delivery of CRISPR\/Cas9 in mouse retinal pigment epithelium cells. Mol. Ther. Nucleic Acids 9, 89\u201399 (2017).","journal-title":"Mol. Ther. Nucleic Acids"},{"key":"656_CR40","volume":"9","author":"T Koo","year":"2018","unstructured":"Koo, T. et al. CRISPR-LbCpf1 prevents choroidal neovascularization in a mouse model of age-related macular degeneration. Nat. Commun. 9, 1855 (2018).","journal-title":"Nat. Commun."},{"key":"656_CR41","doi-asserted-by":"crossref","first-page":"3135","DOI":"10.1167\/iovs.05-1229","volume":"47","author":"M Saint-Geniez","year":"2006","unstructured":"Saint-Geniez, M., Maldonado, A. E. & D\u2019Amore, P. A. VEGF expression and receptor activation in the choroid during development and in the adult. Invest. Ophthalmol. Vis. Sci. 47, 3135\u20133142 (2006).","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"656_CR42","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1016\/j.virol.2014.01.019","volume":"454\u2013455","author":"M Kuzembayeva","year":"2014","unstructured":"Kuzembayeva, M., Dilley, K., Sardo, L. & Hu, W. S. Life of psi: how full-length HIV-1 RNAs become packaged genomes in the viral particles. Virology 454\u2013455, 362\u2013370 (2014).","journal-title":"Virology"},{"key":"656_CR43","doi-asserted-by":"crossref","first-page":"4621","DOI":"10.1093\/nar\/21.19.4621","volume":"21","author":"GG Pickett","year":"1993","unstructured":"Pickett, G. G. & Peabody, D. S. Encapsidation of heterologous RNAs by bacteriophage MS2 coat protein. Nucleic Acids Res. 21, 4621\u20134626 (1993).","journal-title":"Nucleic Acids Res."},{"key":"656_CR44","doi-asserted-by":"crossref","first-page":"e29591","DOI":"10.4161\/mge.29591","volume":"4","author":"Y Cai","year":"2014","unstructured":"Cai, Y. & Mikkelsen, J. G. Driving DNA transposition by lentiviral protein transduction. Mob. Genet. Elem. 4, e29591 (2014).","journal-title":"Mob. Genet. Elem."},{"key":"656_CR45","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1016\/j.omtn.2018.02.006","volume":"11","author":"KA Skipper","year":"2018","unstructured":"Skipper, K. A. et al. Time-restricted PiggyBac DNA transposition by transposase protein delivery using lentivirus-derived nanoparticles. Mol. Ther. Nucleic Acids 11, 253\u2013262 (2018).","journal-title":"Mol. Ther. Nucleic Acids"},{"key":"656_CR46","doi-asserted-by":"crossref","first-page":"939","DOI":"10.1038\/s41591-018-0050-6","volume":"24","author":"RJ Ihry","year":"2018","unstructured":"Ihry, R. J. et al. p53 inhibits CRISPR\u2013Cas9 engineering in human pluripotent stem cells. Nat. Med. 24, 939\u2013946 (2018).","journal-title":"Nat. Med."},{"key":"656_CR47","doi-asserted-by":"crossref","first-page":"1241","DOI":"10.1089\/hum.2005.16.1241","volume":"16","author":"J Ellis","year":"2005","unstructured":"Ellis, J. Silencing and variegation of gammaretrovirus and lentivirus vectors. Hum. Gene Ther. 16, 1241\u20131246 (2005).","journal-title":"Hum. Gene Ther."},{"key":"656_CR48","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1038\/nmeth.3047","volume":"11","author":"NE Sanjana","year":"2014","unstructured":"Sanjana, N. E., Shalem, O. & Zhang, F. Improved vectors and genome-wide libraries for CRISPR screening. Nat. Methods 11, 783\u2013784 (2014).","journal-title":"Nat. Methods"},{"key":"656_CR49","doi-asserted-by":"crossref","first-page":"1012","DOI":"10.1101\/gr.171322.113","volume":"24","author":"S Kim","year":"2014","unstructured":"Kim, S., Kim, D., Cho, S. W., Kim, J. & Kim, J. S. Highly efficient RNA-guided genome editing in human cells via delivery of purified Cas9 ribonucleoproteins. Genome Res. 24, 1012\u20131019 (2014).","journal-title":"Genome Res."},{"key":"656_CR50","doi-asserted-by":"crossref","DOI":"10.1186\/s13059-015-0846-3","volume":"16","author":"Y Dang","year":"2015","unstructured":"Dang, Y. et al. Optimizing sgRNA structure to improve CRISPR-Cas9 knockout efficiency. Genome Biol. 16, 280 (2015).","journal-title":"Genome Biol."},{"key":"656_CR51","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1089\/hum.2015.087","volume":"26","author":"D Wang","year":"2015","unstructured":"Wang, D. et al. Adenovirus-mediated somatic genome editing of Pten by CRISPR\/Cas9 in mouse liver in spite of Cas9-Specific immune responses. Hum. Gene Ther. 26, 432\u2013442 (2015).","journal-title":"Hum. Gene Ther."},{"key":"656_CR52","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1186\/s40478-016-0355-y","volume":"4","author":"B Zeka","year":"2016","unstructured":"Zeka, B. et al. Aquaporin 4-specific T cells and NMO-IgG cause primary retinal damage in experimental NMO\/SD. Acta Neuropathol. Commun. 4, 82 (2016).","journal-title":"Acta Neuropathol. Commun."},{"key":"656_CR53","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1038\/nbt.4192","volume":"36","author":"M Kosicki","year":"2018","unstructured":"Kosicki, M., Tomberg, K. & Bradley, A. Repair of double-strand breaks induced by CRISPR\u2013Cas9 leads to large deletions and complex rearrangements. Nat. Biotechnol. 36, 765\u2013771 (2018).","journal-title":"Nat. Biotechnol."},{"key":"656_CR54","doi-asserted-by":"crossref","first-page":"e0132643","DOI":"10.1371\/journal.pone.0132643","volume":"10","author":"Y Gong","year":"2015","unstructured":"Gong, Y. et al. Optimization of an Image-guided laser-induced choroidal neovascularization model in mice. PLoS ONE 10, e0132643 (2015).","journal-title":"PLoS ONE"},{"key":"656_CR55","doi-asserted-by":"crossref","first-page":"1205","DOI":"10.1038\/mt.2009.10","volume":"17","author":"NH Staunstrup","year":"2009","unstructured":"Staunstrup, N. H. et al. Hybrid lentivirus-transposon vectors with a random integration profile in human cells. Mol. Ther. 17, 1205\u20131214 (2009).","journal-title":"Mol. Ther."},{"key":"656_CR56","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1038\/s41577-018-0117-0","volume":"19","author":"SR Paludan","year":"2019","unstructured":"Paludan, S. R., Reinert, L. S. & Hornung, V. DNA-stimulated cell death: implications for host defence, inflammatory diseases and cancer. Nat. Rev. Immunol. 19, 141\u2013153 (2019).","journal-title":"Nat. Rev. Immunol."},{"key":"656_CR57","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1038\/s41586-018-0500-9","volume":"561","author":"P Akcakaya","year":"2018","unstructured":"Akcakaya, P. et al. In vivo CRISPR editing with no detectable genome-wide off-target mutations. Nature 561, 416\u2013419 (2018).","journal-title":"Nature"},{"key":"656_CR58","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1038\/nbt.3117","volume":"33","author":"SQ Tsai","year":"2015","unstructured":"Tsai, S. Q. et al. GUIDE-seq enables genome-wide profiling of off-target cleavage by CRISPR\u2013Cas nucleases. Nat. Biotechnol. 33, 187\u2013197 (2015).","journal-title":"Nat. Biotechnol."},{"key":"656_CR59","volume":"19","author":"Y Cheng","year":"2018","unstructured":"Cheng, Y. & Tsai, S. Q. Illuminating the genome-wide activity of genome editors for safe and effective therapeutics. Genome Biol. 19, 226 (2018).","journal-title":"Genome Biol."},{"key":"656_CR60","doi-asserted-by":"crossref","first-page":"e0124633","DOI":"10.1371\/journal.pone.0124633","volume":"10","author":"M Stemmer","year":"2015","unstructured":"Stemmer, M., Thumberger, T., del Sol Keyer, M., Wittbrodt, J. & Mateo, J. L. CCTop: an intuitive, flexible and reliable CRISPR\/Cas9 target prediction tool. PLoS ONE 10, e0124633 (2015).","journal-title":"PLoS ONE"},{"key":"656_CR61","doi-asserted-by":"crossref","first-page":"4213","DOI":"10.1172\/JCI65157","volume":"122","author":"T Kurihara","year":"2012","unstructured":"Kurihara, T., Westenskow, P. D., Bravo, S., Aguilar, E. & Friedlander, M. Targeted deletion of Vegfa in adult mice induces vision loss. J. Clin. Invest. 122, 4213\u20134217 (2012).","journal-title":"J. Clin. Invest."},{"key":"656_CR62","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1016\/j.ymthe.2018.11.003","volume":"27","author":"R Grishanin","year":"2019","unstructured":"Grishanin, R. et al. Preclinical evaluation of ADVM-022, a novel gene therapy approach to treating wet age-related macular degeneration. Mol. Ther. 27, 118\u2013129 (2019).","journal-title":"Mol. Ther."},{"key":"656_CR63","first-page":"1073","volume":"6","author":"T Nishimura","year":"2012","unstructured":"Nishimura, T., Machida, S., Harada, T. & Kurosaka, D. Retinal ganglion cell function after repeated intravitreal injections of ranibizumab in patients with age-related macular degeneration. Clin. Ophthalmol. 6, 1073\u20131082 (2012).","journal-title":"Clin. Ophthalmol."},{"key":"656_CR64","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/j.ajo.2019.03.006","volume":"204","author":"EP Rakoczy","year":"2019","unstructured":"Rakoczy, E. P. et al. Three-year follow-up of phase 1 and 2a rAAV.sFLT-1 subretinal gene therapy trials for exudative age-related macular degeneration. Am. J. Ophthalmol. 204, 113\u2013123 (2019).","journal-title":"Am. J. Ophthalmol."},{"key":"656_CR65","doi-asserted-by":"crossref","first-page":"2395","DOI":"10.1016\/S0140-6736(15)00345-1","volume":"386","author":"EP Rakoczy","year":"2015","unstructured":"Rakoczy, E. P. et al. Gene therapy with recombinant adeno-associated vectors for neovascular age-related macular degeneration: 1 year follow-up of a phase 1 randomised clinical trial. Lancet 386, 2395\u20132403 (2015).","journal-title":"Lancet"},{"key":"656_CR66","doi-asserted-by":"crossref","first-page":"3029","DOI":"10.1172\/JCI129861","volume":"129","author":"PA Campochiaro","year":"2019","unstructured":"Campochiaro, P. A. Low risk to retina from sustained suppression of VEGF. J. Clin. Invest. 129, 3029\u20133031 (2019).","journal-title":"J. Clin. Invest."},{"key":"656_CR67","doi-asserted-by":"crossref","first-page":"1114","DOI":"10.1016\/j.cell.2017.02.017","volume":"168","author":"JM Richner","year":"2017","unstructured":"Richner, J. M. et al. Modified mRNA vaccines protect against Zika virus infection. Cell 168, 1114\u20131125 (2017).","journal-title":"Cell"},{"key":"656_CR68","doi-asserted-by":"crossref","first-page":"1070","DOI":"10.1038\/s41587-019-0193-0","volume":"37","author":"BW Thuronyi","year":"2019","unstructured":"Thuronyi, B. W. et al. Continuous evolution of base editors with expanded target compatibility and improved activity. Nat. Biotechnol. 37, 1070\u20131079 (2019).","journal-title":"Nat. Biotechnol."},{"key":"656_CR69","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1038\/nbt.4172","volume":"36","author":"LW Koblan","year":"2018","unstructured":"Koblan, L. W. et al. Improving cytidine and adenine base editors by expression optimization and ancestral reconstruction. Nat. Biotechnol. 36, 843\u2013846 (2018).","journal-title":"Nat. Biotechnol."},{"key":"656_CR70","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1093\/bioinformatics\/btw561","volume":"33","author":"J Park","year":"2017","unstructured":"Park, J., Lim, K., Kim, J. S. & Bae, S. Cas-analyzer: an online tool for assessing genome editing results using NGS data. Bioinformatics 33, 286\u2013288 (2017).","journal-title":"Bioinformatics"},{"key":"656_CR71","doi-asserted-by":"crossref","first-page":"e168","DOI":"10.1093\/nar\/gku936","volume":"42","author":"EK Brinkman","year":"2014","unstructured":"Brinkman, E. K., Chen, T., Amendola, M. & van Steensel, B. Easy quantitative assessment of genome editing by sequence trace decomposition. Nucleic Acids Res. 42, e168 (2014).","journal-title":"Nucleic Acids Res."},{"key":"656_CR72","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1089\/crispr.2018.0014","volume":"1","author":"MG Kluesner","year":"2018","unstructured":"Kluesner, M. G. et al. EditR: a method to quantify base editing from Sanger sequencing. CRISPR J. 1, 239\u2013250 (2018).","journal-title":"CRISPR J."},{"key":"656_CR73","doi-asserted-by":"crossref","first-page":"3094","DOI":"10.1093\/bioinformatics\/bty191","volume":"34","author":"H Li","year":"2018","unstructured":"Li, H. Minimap2: pairwise alignment for nucleotide sequences. Bioinformatics 34, 3094\u20133100 (2018).","journal-title":"Bioinformatics"},{"key":"656_CR74","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1038\/s41592-018-0001-7","volume":"15","author":"FJ Sedlazeck","year":"2018","unstructured":"Sedlazeck, F. J. et al. Accurate detection of complex structural variations using single-molecule sequencing. Nat. Methods 15, 461\u2013468 (2018).","journal-title":"Nat. Methods"},{"key":"656_CR75","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1093\/bioinformatics\/btq033","volume":"26","author":"AR Quinlan","year":"2010","unstructured":"Quinlan, A. R. & Hall, I. M. BEDTools: a flexible suite of utilities for comparing genomic features. Bioinformatics 26, 841\u2013842 (2010).","journal-title":"Bioinformatics"},{"key":"656_CR76","doi-asserted-by":"publisher","unstructured":"Ling, S. et al. Dataset for Lentiviral delivery of co-packaged Cas9 mRNA and a Vegfa-targeting guide RNA prevents wet age-related macular degeneration in mice. Fighare https:\/\/doi.org\/10.6084\/m9.figshare.12611819 (2020).","DOI":"10.6084\/m9.figshare.12611819"}],"container-title":["Nature Biomedical Engineering"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41551-020-00656-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41551-020-00656-y","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41551-020-00656-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,5]],"date-time":"2022-12-05T23:04:03Z","timestamp":1670281443000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41551-020-00656-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,1,4]]},"references-count":76,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2021,2]]}},"alternative-id":["656"],"URL":"https:\/\/doi.org\/10.1038\/s41551-020-00656-y","relation":{},"ISSN":["2157-846X"],"issn-type":[{"value":"2157-846X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,1,4]]},"assertion":[{"value":"3 December 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 November 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 January 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}